Iqtopam

Clonazepam, the active ingredient in Iqtopam, is a benzodiazepine presented as a formulation for intramuscular and intravenous use. It is used to manage certain seizure types, panic disorder, and anxiety in adults and children as prescribed.

GNH USA supplies Iqtopam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clonazepam acts on the central nervous system to control abnormal neuronal firing associated with several neurological and psychiatric conditions. - Epilepsy (absence and myoclonic seizures): reduces seizure frequency and severity. - Panic disorder: diminishes the intensity and frequency of panic attacks. - Anxiety disorders: provides short‑term relief of acute anxiety symptoms.

Clonazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: light‑headed sensation or loss of balance. - Ataxia: impaired coordination and unsteady gait. - Cognitive impairment: difficulty concentrating or memory lapses. - Headache: mild to moderate head pain. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Depression or suicidal thoughts: mood changes requiring urgent evaluation. - Paradoxical aggression: increased agitation or hostility. - Dependence and withdrawal: physical dependence with abrupt discontinuation. - Hepatic dysfunction: abnormal liver enzyme elevations.

Clonazepam requires careful monitoring due to its central nervous system effects and potential for dependence. - Assess renal and hepatic function: adjust use if impairment is present. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Caution in the elderly: increased sensitivity to sedation and falls. - Contraindicated with acute narrow‑angle glaucoma: may increase intra‑ocular pressure. - Monitor for respiratory depression: especially when combined with opioids or other depressants. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Clonazepam can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids (e.g., morphine, fentanyl): additive respiratory depression. - Barbiturates (e.g., phenobarbital): increased sedation and risk of overdose. - Other benzodiazepines: cumulative CNS depression.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs, SNRIs): may enhance sedation. - Anticonvulsants (e.g., carbamazepine): may reduce clonazepam plasma levels. - Antifungal azoles (e.g., ketoconazole): can increase clonazepam concentrations. - Alcohol: potentiates sedative effects. - CYP3A4 inhibitors (e.g., erythromycin): may raise drug exposure.